Biosense Webster EMEA clinical trials
A country office of Johnson & Johnson
The registry lists 3 studies whose lead sponsor is Biosense Webster EMEA. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 4, 2025.
Registry sponsor names on this page
- Biosense Webster EMEA3 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Johnson & Johnson studies →
- CACAF2 Study: Catheter Ablation for Cure of Atrial FibrillationTerminatedNCT00227344Phase 4
Sponsor listed in the registry: Biosense Webster EMEA
- FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)CompletedNCT00137540Phase 3
Sponsor listed in the registry: Biosense Webster EMEA
- European Carto® XP REgistry for Validating Specialized CFAE SOftwareCompletedNCT00812916
Sponsor listed in the registry: Biosense Webster EMEA